Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

被引:301
作者
McCullers, JA [1 ]
Bartmess, KC [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
关键词
D O I
10.1086/368163
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A lethal synergism exists between influenza virus and Streptococcus pneumoniae, accounting for excess mortality during influenza epidemics. Using a model of viral-bacterial synergism, we assessed the role that the influenza virus neuraminidase (NA) has in priming mice for pneumococcal infection. Administration of the selective NA inhibitor oseltamivir improved survival, independent of viral replication and morbidity from influenza. Both pathologic examination of the lungs and live imaging of pneumonic lesions, using a bioluminescent pneumococcus, suggested that the effect of NA inhibition was to limit the extent of pneumococcal pneumonia during early infection. Adherence assays and immunohistochemical staining for sialic acids in lungs from infected mice demonstrated that the influenza virus NA potentiates development of pneumonia by stripping sialic acid from the lung, thus exposing receptors for pneumococcal adherence. Selective NA inhibitors may be useful clinically to interrupt this novel mechanism of synergism and to prevent excess mortality from secondary bacterial pneumonia.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 42 条
[1]   INFLUENZA-A VIRUS-INDUCED POLYMORPHONUCLEAR LEUKOCYTE DYSFUNCTION IN THE PATHOGENESIS OF EXPERIMENTAL PNEUMOCOCCAL OTITIS-MEDIA [J].
ABRAMSON, JS ;
GIEBINK, GS ;
QUIE, PG .
INFECTION AND IMMUNITY, 1982, 36 (01) :289-296
[2]   Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins [J].
Berry, AM ;
Paton, JC .
INFECTION AND IMMUNITY, 2000, 68 (01) :133-140
[3]   Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older:: a prospective study [J].
Christenson, B ;
Lundbergh, P ;
Hedlund, J ;
Örtqvist, Å .
LANCET, 2001, 357 (9261) :1008-1011
[4]   Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon [J].
Francis, KP ;
Yu, J ;
Bellinger-Kawahara, C ;
Joh, D ;
Hawkinson, MJ ;
Xiao, G ;
Purchio, TF ;
Caparon, MG ;
Lipsitch, M ;
Contag, PR .
INFECTION AND IMMUNITY, 2001, 69 (05) :3350-3358
[5]   COMPARISON OF INFECTION-RATES AND SEVERITY OF ILLNESS FOR INFLUENZA-A SUBTYPES H1N1 AND H3N2 [J].
FRANK, AL ;
TABER, LH ;
WELLS, JM .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (01) :73-80
[6]   Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment [J].
Fritz, RS ;
Hayden, FG ;
Calfee, DP ;
Cass, LMR ;
Peng, AW ;
Alvord, WG ;
Strober, W ;
Straus, SE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :586-593
[7]   DIFFERENT VIRULENCE OF INFLUENZA-A VIRUS-STRAINS AND SUSCEPTIBILITY TO PNEUMOCOCCAL OTITIS-MEDIA IN CHINCHILLAS [J].
GIEBINK, GS ;
WRIGHT, PF .
INFECTION AND IMMUNITY, 1983, 41 (03) :913-920
[8]   MORTALITY AND INFLUENZA [J].
GLEZEN, WP ;
PAYNE, AA ;
SNYDER, DN ;
DOWNS, TD .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (03) :313-321
[9]   Current strategies for management of influenza in the elderly population [J].
Gravenstein, S ;
Davidson, HE .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (06) :729-737
[10]  
Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x